You need to log in or sign up before continuing.  

Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign up Log in
Powered By

Top 2 search results for "Hympavzi" in Resources. To see all results and access other features, sign up for free.

... FDA Approves Pfizer’s Hympavzi (Marstacimab-Hncq) for the Treatment of Adults and Adolescents With Hemophilia A or B Without Inhibitors — Pfizer Immune Tolerance To Treat an Inhibitor — Hemophilia of Georgia Hemophilia C — Cleveland Clinic ...
Hemophilia A vs. B: What Are the Differences?
... FDA Approves Pfizer’s Hympavzi (Marstacimab-Hncq) for the Treatment of Adults and Adolescents With Hemophilia A or B Without Inhibitors — Pfizer Immune Tolerance To Treat an Inhibitor — Hemophilia of Georgia Hemophilia C — Cleveland Clinic ...
... They work by restoring the balance between factors that help the blood clot and factors that prevent the blood from clotting.Concizumab-mtci (Alhemo) and marstacimab-hncq (Hympavzi) help blood clot better by blocking a protein called tissue factor pathway inhibitor, which normally slows down clotting. ...
How To Treat Hemophilia: 6 Treatment Options
... They work by restoring the balance between factors that help the blood clot and factors that prevent the blood from clotting.Concizumab-mtci (Alhemo) and marstacimab-hncq (Hympavzi) help blood clot better by blocking a protein called tissue factor pathway inhibitor, which normally slows down clotting. ...